Logo image of CXP

COLUMBIA PROPERTY TRUST INC (CXP) Stock Fundamental Analysis

NYSE:CXP - New York Stock Exchange, Inc. - REIT

19.28  +0.02 (+0.1%)

After market: 19.28 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CXP. CXP was compared to 130 industry peers in the Diversified REITs industry. CXP has a bad profitability rating. Also its financial health evaluation is rather negative. CXP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CXP had positive earnings in the past year.
CXP Yearly Net Income VS EBIT VS OCF VS FCFCXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 50M 100M 150M 200M

1.2 Ratios

Industry RankSector Rank
ROA 2.06%
ROE 3.29%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CXP Yearly ROA, ROE, ROICCXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 1 2 3 4

1.3 Margins

Industry RankSector Rank
OM 1.28%
PM (TTM) 32.87%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CXP Yearly Profit, Operating, Gross MarginsCXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

CXP has less shares outstanding than it did 1 year ago.
The debt/assets ratio for CXP has been reduced compared to a year ago.
CXP Yearly Shares OutstandingCXP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M
CXP Yearly Total Debt VS Total AssetsCXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 1B 2B 3B 4B

2.2 Solvency

A Debt/Equity ratio of 0.52 indicates that CXP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CXP Yearly LT Debt VS Equity VS FCFCXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1623.98% over the past year.
CXP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.75% yearly.
The Revenue for CXP has decreased by -17.14% in the past year. This is quite bad
The Revenue for CXP have been decreasing by -11.89% on average. This is quite bad
EPS 1Y (TTM)1623.98%
EPS 3Y521.02%
EPS 5Y42.75%
EPS Q2Q%-287.59%
Revenue 1Y (TTM)-17.14%
Revenue growth 3Y1.32%
Revenue growth 5Y-11.89%
Sales Q2Q%-22.96%

3.2 Future

Based on estimates for the next years, CXP will show a very strong growth in Earnings Per Share. The EPS will grow by 117.25% on average per year.
Based on estimates for the next years, CXP will show a decrease in Revenue. The Revenue will decrease by -4.18% on average per year.
EPS Next Y-54.62%
EPS Next 2Y-54.39%
EPS Next 3Y181.38%
EPS Next 5Y117.25%
Revenue Next Year-0.52%
Revenue Next 2Y-0.02%
Revenue Next 3Y-4.29%
Revenue Next 5Y-4.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXP Yearly Revenue VS EstimatesCXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CXP Yearly EPS VS EstimatesCXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.1 0.2 0.3 0.4 0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.66, which means the current valuation is very expensive for CXP.
The average S&P500 Price/Earnings ratio is at 28.98. CXP is around the same levels.
A Price/Forward Earnings ratio of 4588.96 indicates a quite expensive valuation of CXP.
When comparing the Price/Forward Earnings ratio of CXP to the average of the S&P500 Index (21.38), we can say CXP is valued expensively.
Industry RankSector Rank
PE 29.66
Fwd PE 4588.96
CXP Price Earnings VS Forward Price EarningsCXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 1K 2K 3K 4K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.45
CXP Per share dataCXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CXP's earnings are expected to grow with 181.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y-54.39%
EPS Next 3Y181.38%

More info and screens

5

5. Dividend

5.1 Amount

CXP has a Yearly Dividend Yield of 4.37%, which is a nice return.
CXP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 4.37%

5.2 History

The dividend of CXP has a limited annual growth rate of 1.64%.
CXP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)1.64%
Div Incr YearsN/A
Div Non Decr YearsN/A
CXP Yearly Dividends per shareCXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

117.96% of the earnings are spent on dividend by CXP. This is not a sustainable payout ratio.
The dividend of CXP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP117.96%
EPS Next 2Y-54.39%
EPS Next 3Y181.38%
CXP Yearly Income VS Free CF VS DividendCXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 50M 100M 150M
CXP Dividend Payout.CXP Dividend Payout, showing the Payout Ratio.CXP Dividend Payout.PayoutRetained Earnings

More info and screens

COLUMBIA PROPERTY TRUST INC

NYSE:CXP (12/7/2021, 8:47:32 PM)

After market: 19.28 0 (0%)

19.28

+0.02 (+0.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners1.01%
Inst Owner Change0%
Ins Owners0.13%
Ins Owner Change0%
Market Cap2.20B
Analysts49.09
Price Target19.09 (-0.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.37%
Yearly Dividend0.84
Dividend Growth(5Y)1.64%
DP117.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.66
Fwd PE 4588.96
P/S 8.67
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB N/A
EV/EBITDA 41.45
EPS(TTM)0.65
EY3.37%
EPS(NY)0
Fwd EY0.02%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.22
BVpS22.2
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 2.06%
ROE 3.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.28%
PM (TTM) 32.87%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1623.98%
EPS 3Y521.02%
EPS 5Y42.75%
EPS Q2Q%-287.59%
EPS Next Y-54.62%
EPS Next 2Y-54.39%
EPS Next 3Y181.38%
EPS Next 5Y117.25%
Revenue 1Y (TTM)-17.14%
Revenue growth 3Y1.32%
Revenue growth 5Y-11.89%
Sales Q2Q%-22.96%
Revenue Next Year-0.52%
Revenue Next 2Y-0.02%
Revenue Next 3Y-4.29%
Revenue Next 5Y-4.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A